Vaxcyte, Inc.·4

Aug 18, 6:02 PM ET

Wright-Mitchell Jane 4

4 · Vaxcyte, Inc. · Filed Aug 18, 2021

Insider Transaction Report

Form 4
Period: 2021-08-16
Mitchell Jane Wright
General Counsel
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-08-162,500187,468 total
    Exercise: $2.03Exp: 2029-03-20Common Stock (2,500 underlying)
  • Sale

    Common Stock

    2021-08-16$26.00/sh2,500$65,0003,125 total
  • Exercise/Conversion

    Common Stock

    2021-08-16$2.03/sh+2,500$5,0755,625 total
Footnotes (2)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION